Show items per page
Elements: 19
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results Zilli, Thomas; Jorcano, Sandra; Bral, Samuel; Rubio, Carmen; ... Miralbell, Raymond 2020
add to browser selection
Quantification of perineural invasion focus after radical prostatectomy could improve predictive power of recurrence Wu, Shulin; Xie, Ling; Lin, Sharron X; Wirth, Grégory Johann; ... Wu, Chin-Lee 2020
add to browser selection
PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial De Bruycker, A.; Spiessens, A.; Dirix, P.; Koutsouvelis, N.; ... Ost, P. 2020
add to browser selection
Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications Diamand, Romain; Ploussard, Guillaume; Roumiguié, Mathieu; Malavaud, Bernard; ... Albisinni, Simone 2020
add to browser selection
Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI Achard, Verane; Lamanna, Giorgio; Denis, Antoine; De Perrot, Thomas Benoît; ... Zilli, Thomas 2019
add to browser selection
Clinical impact of 68Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction Müller, Julian; Ferraro, Daniela A.; Muehlematter, Urs J.; Garcia Schüler, Helena I.; ... Burger, Irene A. 2019
add to browser selection
Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice Panje, Cedric; Zilli, Thomas; Pra, Alan Dal; Arnold, Winfried; ... Putora, Paul Martin 2019
add to browser selection
Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter? Achard, Verane; Jorcano, Sandra; Rouzaud, Michel; Escudé, Lluís; ... Zilli, Thomas 2019
add to browser selection
Oligometastatic prostate cancer: The game is afoot Lancia, Andréa; Zilli, Thomas; Achard, Verane; Dirix, Piet; ... Ost, Piet 2019
add to browser selection
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial Zilli, Thomas; Franzese, Ciro; Bottero, Marta; Giaj-Levra, Niccolò; ... Miralbell, Raymond 2019
add to browser selection
First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9 Gnesin, Silvano; Cicone, Francesco; Mitsakis, Periklis; Van der Gucht, Axel; ... Prior, John O 2018
add to browser selection
Effects of age and stage on prostate cancer survival in Switzerland Rohrmann, Sabine; Bouchardy Magnin, Christine; Mousavi, Mohsen; Lorez, Matthias; Arndt, Volker 2016
add to browser selection
Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiation therapy in localized or locally-advanced prostate cancer Zilli, Thomas 2015
add to browser selection
Radical prostatectomy and pelvic lymph node dissection for organ-confined prostate cancer. Preoperative planning, surgical technique and outcomes Mattei, Agostino 2013
add to browser selection
Trends in Prostate Cancer Survival in Switzerland Dehler, Silvia; Rohrmann, Sabine; Lorez, Matthias; Clough-Gorr, Kerri 2013
add to browser selection
Combination therapy and targeted drug delivery: strategies for enhanced photodynamic therapy Zuluaga Estrada, Maria Fernanda 2011
add to browser selection
ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene NKX3.1 in prostate cancer Kunderfranco, Paolo 2010
add to browser selection
Tumor suppressor role of the epithelial-specific ets transcription factor ESE-3 in prostate cancer and therapeutic implications Cangemi, Romina 2008
add to browser selection
Biodegradable microparticles for sustained release of a new GnRH antagonist - part I: Screening commercial PLGA and formulation technologies Schwach, Grégoire; Oudry, Nathalie; Delhomme, Sophie; Lück, Martin; ... Gurny, Robert 2003